Tag: CLL

  • Nation & World

    Vaccine works on hard-to-treat leukemia


    Scientists at Harvard-affiliated Dana-Farber Cancer Institute observed a strong and selective immune response in some patients who received several doses of a “personalized” tumor vaccine composed of their own inactivated leukemia cells combined with an immune stimulant.

    4 minutes